L-에르고티오네인 시장 예측(-2030년) : 유형별, 원료별, 형태별, 유통 채널별, 용도별, 지역별 세계 분석

According to Stratistics MRC, the Global L-ergothioneine Market is accounted for $39.5 million in 2023 and is expected to reach $312.8 million by 2030 growing at a CAGR of 34.4% during the forecast period. L-ergothioneine is a naturally occurring amino acid derivative with potent antioxidant properties. It is synthesized by certain fungi and bacteria and is found in trace amounts in various foods. L-ergothioneine acts as a scavenger of harmful free radicals, protecting cells from oxidative damage and potentially offering health benefits, including anti-inflammatory and anti-aging effects.

According to the National Cancer Institute, the antioxidant property of mushrooms may help to reduce the risk of breast, prostate, lung, and other cancers.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases

The increasing prevalence of chronic diseases serves as a driver in the L-ergothioneine market. Chronic diseases are characterized by oxidative stress and inflammation, leading to tissue damage and dysfunction. L-ergothioneine, with its potent antioxidant and anti-inflammatory properties, has shown potential for mitigating oxidative damage and inflammation, thereby offering therapeutic benefits in the prevention and management of chronic diseases. This drives the demand for L-ergothioneine as a functional ingredient in dietary supplements and pharmaceutical formulations.

Restraint:

High production costs

The complex and specialized production process, which involves fermentation or chemical synthesis, requires sophisticated equipment and skilled labor, contributing to elevated manufacturing expenses. Additionally, the limited natural sources of L-ergothioneine further exacerbate production costs. These high expenses may result in higher prices for L-ergothioneine products, potentially hindering market growth and adoption.

Opportunity:

Development of synthetic L-ergothioneine

Synthetic production methods can offer advantages such as cost-effectiveness, scalability, and quality control compared to extraction from natural sources. This can meet the increasing demand for L-ergothioneine in various industries, including pharmaceuticals, cosmetics, and dietary supplements. Moreover, synthetic production allows for customization and formulation flexibility, enabling the creation of new applications and enhancing the accessibility of L-ergothioneine on the market.

Threat:

Presence of counterfeit or low-quality L-ergothioneine products

The presence of counterfeit or low-quality L-ergothioneine products poses a threat to the market. These products may lack efficacy, purity, and safety, leading to potential health risks for consumers. Furthermore, they undermine consumer trust in L-ergothioneine and the industry as a whole. The proliferation of such products can also tarnish the reputation of legitimate manufacturers and distributors, which hinders market growth.

Covid-19 Impact:

The COVID-19 pandemic had a significant impact on the L-ergothioneine market. The increased focus on health and immunity during the pandemic led to a growing interest in antioxidants like L-ergothioneine. However, disruptions in supply chains and manufacturing operations affected production and distribution, resulting in fluctuating availability and pricing. Despite the challenges, the pandemic highlighted the potential health benefits of L-ergothioneine, driving demand for the ingredient.

The powder segment is expected to be the largest during the forecast period

The powder segment is anticipated to be the largest during the forecast period in the L-ergothioneine market due to various factors. Powdered L-ergothioneine offers versatility in formulation and application across various industries, including pharmaceuticals, cosmetics, and dietary supplements. Additionally, powdered form facilitates easy handling, storage, and blending into formulations, making it preferred by manufacturers. Moreover, powdered L-ergothioneine can be easily standardized and formulated into different products, driving its dominance in the market.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

The pharmaceuticals segment is projected to experience the highest growth rate during the forecast period in the L-ergothioneine market. This growth can be attributed to the increasing research and development activities focused on exploring the therapeutic potential of L-ergothioneine in treating various medical conditions. Additionally, the rising prevalence of chronic diseases and age-related disorders has fueled demand for innovative pharmaceutical formulations containing L-ergothioneine, driving its growth in the pharmaceuticals segment.

Region with largest share:

North America is expected to dominate the L-ergothioneine market due to the region's advanced healthcare infrastructure, increasing consumer awareness about health and wellness, and the presence of key players in the pharmaceutical and cosmetic industries. Additionally, robust research and development activities, coupled with a growing demand for dietary supplements and skincare products containing L-ergothioneine, further contribute to North America's anticipated largest market share in the L-ergothioneine market.

Region with highest CAGR:

The Asia-Pacific region is poised for rapid growth in the L-ergothioneine market due to the region's increasing population, rising disposable incomes, and growing awareness of health and wellness. Additionally, the expanding pharmaceutical, cosmetic, and dietary supplement industries in countries like China, Japan, and India present significant opportunities for L-ergothioneine manufacturers. Moreover, favorable government initiatives supporting research and development activities further contribute to the region's potential for rapid market growth.

Key players in the market

Some of the key players in L-ergothioneine market include Alfa Aesar, BOC Sciences, Cayman Chemical, ChemFaces, Chemieliva Pharmaceutical Co., Ltd., Chemwill Asia Co., Ltd., Evonik Industries AG, Gea Group AG, Gold Biotechnology, Inc., Hangzhou J&H Chemical Co., Ltd., Hangzhou Lingrui Chemical Co., Ltd., Hefei TNJ Chemical Industry Co., Ltd., Henan Tianfu Chemical Co., Ltd., Kanto Chemical Co., Inc., Merck KGaA, Santa Cruz Biotechnology, Inc., Shanghai Haoyuan Chemexpress Co., Ltd., Suzhou Health Chemicals Co., Ltd. and Zhonglan Industry Co., Ltd.

Key Developments:

In June 2022, BOC Sciences, a leading CRO in the pharmaceutical industry, demonstrates its comprehensive strength through innovative lysosome-targeting chimera (LYTAC) degradation technology solutions developed within the field of targeted protein degradation. LYTAC is a new technology that can degrade extracellular proteins and membrane-related proteins through the endosomal/lysosomal pathway.

In October 2021, Thermo Fisher Scientific recently announced consolidation of its product portfolio brands Acros Organics, Alfa Aesar and Maybridge transitioning to one unified brand, Thermo Scientific. This transition is a response to the customer's feedback to simplify the buying journey experience. The transition will be effective from mid- October 2021 and all products of Alfa Aesar(TM), Acros, Organics(TM) and Maybridge(TM) packed and labeled from mid-October 2021 onwards will be branded as Thermo Scientific(TM).

Types Covered:

• Fermentation-based Production
• Chemical Synthesis
• Biosynthesis

Sources Covered:

• Mushrooms
• Algae
• Bacteria

Forms Covered:

• Powder
• Liquid
• Capsule
• Other Forms

Distribution Channels Covered:

• Direct Sales
• Distributors
• Online Retail
• Specialty Stores

Applications Covered:

• Pharmaceuticals
• Personal Care & Cosmetics
• Food & Beverages
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global L-ergothioneine Market, By Type

• 5.1 Introduction
• 5.2 Fermentation-based Production
• 5.3 Chemical Synthesis
• 5.4 Biosynthesis

6 Global L-ergothioneine Market, By Source

• 6.1 Introduction
• 6.2 Mushrooms
  • 6.2.1 Medicinal Mushrooms
  • 6.2.2 Edible Mushrooms
• 6.3 Algae
• 6.4 Bacteria

7 Global L-ergothioneine Market, By Form

• 7.1 Introduction
• 7.2 Powder
• 7.3 Liquid
• 7.4 Capsule
• 7.5 Other Forms

8 Global L-ergothioneine Market, By Distribution Channel

• 8.1 Introduction
• 8.2 Direct Sales
• 8.3 Distributors
• 8.4 Online Retail
• 8.5 Specialty Stores

9 Global L-ergothioneine Market, By Application

• 9.1 Introduction
• 9.2 Pharmaceuticals
• 9.3 Personal Care & Cosmetics
• 9.4 Food & Beverages
• 9.5 Other Applications

10 Global L-ergothioneine Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Alfa Aesar
• 12.2 BOC Sciences
• 12.3 Cayman Chemical
• 12.4 ChemFaces
• 12.5 Chemieliva Pharmaceutical Co., Ltd.
• 12.6 Chemwill Asia Co., Ltd.
• 12.7 Evonik Industries AG
• 12.8 Gea Group AG
• 12.9 Gold Biotechnology, Inc.
• 12.10 Hangzhou J&H Chemical Co., Ltd.
• 12.11 Hangzhou Lingrui Chemical Co., Ltd.
• 12.12 Hefei TNJ Chemical Industry Co., Ltd.
• 12.13 Henan Tianfu Chemical Co., Ltd.
• 12.14 Kanto Chemical Co., Inc.
• 12.15 Merck KGaA
• 12.16 Santa Cruz Biotechnology, Inc.
• 12.17 Shanghai Haoyuan Chemexpress Co., Ltd.
• 12.18 Suzhou Health Chemicals Co., Ltd.
• 12.19 Zhonglan Industry Co., Ltd.